Ruthy Tal-Jasper

Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae

Hadas Ofer-Friedman, Coral Shefler, Sarit Sharma et al. · Infection Control and Hospital Epidemiology · 2015 · 96 citations

Life Sciences, Infectious Diseases, Antimicrobial Pharmacotherapy +14

Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections

Ruthy Tal-Jasper, David Katz, Nadav Amrami et al. · Antimicrobial Agents and Chemotherapy · 2016 · 77 citations · Full text

Life Sciences, Infectious Diseases, Antimicrobial Resistance +16

Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae

Violet Leibman, Emily T. Martin, Ruthy Tal-Jasper et al. · Annals of Clinical Microbiology and Antimicrobials · 2015 · 22 citations · Full text

Life Sciences, Clinical Pharmacy, Infectious Diseases +17

The Complex Epidemiology of Carbapenem-Resistant<i>Enterobacter</i>Infections: A Multicenter Descriptive Analysis

Tsilia Lazarovitch, Keren Amity, Joseph Coyle et al. · Infection Control and Hospital Epidemiology · 2015 · 18 citations

Life Sciences, Infectious Diseases, Microbiology +17

Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258

Sorabh Dhar, Emily T. Martin, Paul Lephart et al. · Open Forum Infectious Diseases · 2016 · 18 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17